Home > Latest NewsLatest News
The content below contains the latest news affecting community pharmacy owners and their teams throughout Scotland. If you can’t find something or you have a question please get in touch with us at webteam@cps.scot
PCA(P)(2024)33 - Extension to Serious Shortage Protocols for Ramipril 2.5mg Tablets and Creon® Gastro-resistant Capsules
This Circular advises community pharmacy contractors that the Serious Shortage Protocol (SSP) for Ramipril 2.5mg tablets due to expire on 15 November 2024 has been extended until Friday 29 November 2024.
PCA(P)(2024) 31 – Extension to SSP for Isosorbide Mononitrate (Monomax XL 60mg) Modified-Release Tablet
This Circular advises community pharmacy contractors that the Serious Shortage Protocol for isosorbide mononitrate (Monomax® XL) 60mg modified release tablet due to expire on 18 October 2024 has been extended until Friday 15 November 2024.
PCA(P)(2024)24-27 - SSP for Isosorbide Mononitrate (Chemydur® 60XL) Tabs
To advise of a Serious Shortage Protocol (SSP) in place for isosorbide mononitrate (Chemydur® 60XL) modified release tablet, from 6 September 2024 to 27 September 2024.
PCA(P)(2024)22- Serious Shortage Protocol for Cefalexin 500mg Tabs
To advise of a Serious Shortage Protocol (SSP) in place for cefalexin 500mg tablets, from 6 August 2024 to 27 September 2024.
PCA(P)(2024)21- Serious Shortage Protocol for Ramipril 2.5mg Tabs
To advise of a Serious Shortage Protocol (SSP) in place for ramipril 2.5mg tablets, from 6 August 2024 to 15 November 2024.
PCA(P)(2024)09 - Reactivation of SSP for Clarithromycin 125mg/5ml and 250mg/5ml Oral Suspension
This Circular advises Health Boards and community pharmacy contractors that the two UK-wide Serious Shortage Protocols (SSPs) for Clarithromycin 125mg/5ml and 250mg/5ml oral suspension have been reactivated on 22 May 2024. The new end date for both SSPs is now 21 June 2024.
PCA(P)(2024)08 - SSP: Creon® 25000 Gastro-Resistant Capsules
To advise of a Serious Shortage Protocol (SSP) in place for Creon® 25000 gastro-resistant capsules, from 24 May 2024 to 22 November 2024.
PCA(P)(2024)07 - Serious Shortage Protocol: Creon® 10000 Gastro-Resistant Capsules
To advise of a Serious Shortage Protocol (SSP) in place for Creon® 10000 gastro-resistant capsules, from 24 May 2024 to 22 November 2024.
PCA(P)(2023)43 - Extension to SSP for Clarithromycin
This Circular advises NHS Boards and community pharmacy contractors that the UK-wide Serious Shortage Protocol (SSP) for Clarithromycin
PCA(P)(2023)41 - SSP for Issued for Clarithromycin
This Circular advises NHS Boards and community pharmacy contractors that the UK-wide Serious Shortage Protocol (SSP) for Clarithromycin
PCA(P)(2023)40 - Extension to SSP issued for Estradot®
This Circular advises NHS Boards and community pharmacy contractors that the UK-wide active Serious Shortage Protocol (SSP) for Estradot®
PCA(P)(2023)38 - Extension to SSP for Jext 300 micrograms/ 0.3mL
This Circular advises NHS Boards and community pharmacy contractors that the UK-wide active Serious Shortage Protocol (SSP) for Jext® 300 micrograms/ 0.3mL (1 in 1000) solution for injection auto-injector pen
PCA(P)(2023)37 - SSP for Estradot® 100 Microgram Patches
This Circular advises community pharmacy contractors that the UK-wide active Serious Shortage Protocol (SSP) for Estradot® (estradiol hemihydrate) 100 microgram patches
PCA(P)(2023)36 - SSP for Clarithromycin
This Circular advises community pharmacy contractors that two of the UK-wide Serious Shortage Protocols (SSPs) for Clarithromycin antibiotic
PCA(P)(2023)33 - SSP for Estradot®
This Circular advises community pharmacy contractors that the UK-wide active Serious Shortage Protocol (SSP) for Estradot® (estradiol hemihydrate) 100 microgram patches
PCA(P)(2023)32 - SSP for Utrogestan®
This Circular advises community pharmacy contractors that the UK-wide active Serious Shortage Protocol (SSP) for Utrogestan®
PCA(P)(2023)31 - SSP for Jext 300 micrograms/0.3mL
To advise of a Serious Shortage Protocol (SSP) in place for Jext® 300 micrograms/0.3mL (1 in 1000) solution for injection auto-injector pen, from 21 August 2023 to 15 September 2023.
PCA(P)(2023)30 - SSP for Estradot (Estradiol hemihydrate)
To advise of a Serious Shortage Protocol (SSP) in place for Estradot® (Estradiol hemihydrate) 100 microgram patches, from 21 August 2023 to 8 September 2023.
PCA(P)(2023)29 - SSP for Progynova®
This Circular advises community pharmacy contractors that the Serious Shortage Protocol (SSP) for Progynova®
PCA(P)(2023)28 - Extension to SSP for Utrogestan® 100mg Capsules
This Circular advises community pharmacy contractors that the UK-wide active Serious Shortage Protocol (SSP) for Utrogestan® (micronised progesterone) 100mg capsules